Nature, Published online: 23 June 2026; doi:10.1038/d41586-026-01812-1
The scientific community awaits a patent for recombinant DNA technology, and experimentation with an anaesthetic from puffballs, in our weekly dip into Nature’s archive.
Trending
- Turaki-led PDP meets UK High Commission, raises concerns over alleged Nigeria’s shrinking opposition space
- MLB Best Home Run Bets For August 8, 2026—Schwarber And Harper
- Why there’s a row about standing up while drinking in central London
- Scientists tracked 12 people in Antarctica for 10 months—what happened could shape future Mars missions
- The best pickleball equipment for beginners: paddles, balls and more to hit the court | Life and style
- Jared Leto: Campaigners call for concerts to be cancelled
- Gov Lawal receives ZIK Pan-African Leadership Award in Ghana
- Extend Pay Rise for Military to Other Security Agencies, Rewane Tells FG – THISDAYLIVE
A 1970s patent that changed the course of commercial biotechnology
